Shrimp Disease Prevention & Therapeutics Market Comprehensive Size and Share Assessment 2026 to 2035

AI Briefing

• – Shrimp disease prevention and therapeutics market to reach USD 1.45 billion by 2035 due to increasing demand for sustainable seafood, growing shrimp farming industry, and rising awareness of aquaculture health issues.
• – Key players in the shrimp disease prevention and therapeutics market include Zoetis, Merck Animal Health, and Ceva Animal Health, with Zoetis leading the market share due to its extensive portfolio of aquaculture products.
• – The demand for shrimp disease prevention and therapeutics is expected to be driven by the increasing global shrimp production, rising health concerns among consumers, and the need for sustainable aquaculture practices.